We found that seven types of cancer had a significant statistical overall survival in differential expression of the CDKN2A gene of which four cancers were associated with high gene expression, including COAD (p = 0.011), MESO (p = 5.9x10-7 ), PCPG (p = 0.016), LIHC (p = 0.0045) (supplementary Figures 14A-14D) and three cancers associated with low gene expression, including ACC, UCES, and UVM. Here, CDKN2A is linked to cancer.